Nursing management for percutaneous coronary intervention in patients with acute coronary syndrome

WANG Jie; SHI Dongmei

doi:10.7619/jcmp.20211579

Journal of Clinical Medicine in Practice > 2021 > 25(19): 78-82. > DOI: 10.7619/jcmp.20211579

WANG Jie, SHI Dongmei. Nursing management for percutaneous coronary intervention in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 78-82. DOI: 10.7619/jcmp.20211579

Citation:

PDF (1106 KB)

Nursing management for percutaneous coronary intervention in patients with acute coronary syndrome

Department of Cardiovascular Medicine, Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, 210029

More Information

Received Date: April 13, 2021
Available Online: October 27, 2021
Published Date: October 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the value of perioperative nursing risk management for percutaneous coronary intervention (PCI) in patients with acute coronary syndrome.
Methods The nursing risk management conditions of 152 patients with acute coronary syndrome during PCI was analyzed retrospectively, and they were divided into occurrence group (38 cases with adverse cardiovascular events) and non-occurrence group (114 cases without adverse cardiovascular events) according to incidence of adverse cardiovascular events. The general data of the two groups were compared, the independent factors affecting adverse cardiovascular events were explored by binary Logistic regression analysis, and the predictive value of each independent factor was analyzed by receiver operating characteristic (ROC) curve.
Results After implementation of risk management, there were 38 of 152 cases (25.00%) with adverse cardiovascular events. Binary Logistic regression analysis showed that history of hypertension, body mass index (BMI) ≥ 24 kg/m², smoking history, high density lipoprotein cholesterol (HDL-C) ≤ 0.9 mmol/L, low density lipoprotein cholesterol (LDL-C) >2.6 mmol/L and leukocyte count ≥ 10×10⁹/L were the independent factors for adverse cardiac events. The ROC curve analysis showed that the AUCs of leukocyte count, smoking history, history of hypertension, HDL-C, LDL-C and BMI in the early prediction of adverse cardiac events were 0.702, 0.732, 0.667, 0.724, 0.754 and 0.706, respectively.
Conclusion The effect of perioperative nursing risk management in patients with acute coronary syndrome during PCI treatment is remarkable, but it is still affected by many factors, so it is necessary to identify and control risk factors in early stage.
- acute coronary syndrome,
- percutaneous coronary intervention,
- adverse cardiac events,
- blood lipids

FullText(HTML)

References (17)

References

[1]	吴高波, 邵磊, 海冰峰, 等. 1型与2型Wellens综合征冠脉病变及风险评估对比研究[J]. 郑州大学学报: 医学版, 2018, 53(3): 365-369. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK201803024.htm
[2]	李明英. 替格瑞洛与氯吡格雷对急性冠脉综合征患者经皮冠状动脉介入治疗术后血小板功能和炎性因子的影响比较[J]. 中国基层医药, 2017, 24(3): 439-443. doi: 10.3760/cma.j.issn.1008-6706.2017.03.030
[3]	负荷量加高维持量阿托伐他汀对ACS行PCI患者炎症因子及血管内皮功能的影响[J]. 河北医科大学学报, 2018, 39(10): 1131-1134, 1157.
[4]	郭浩, 齐茗. 高危急性冠脉综合征患者PCI术后不良心血管事件发生的影响因素[J]. 解放军预防医学杂志, 2019, 37(11): 63-64. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX201911073.htm
[5]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 非ST段抬高型急性冠状动脉综合征基层诊疗指南(实践版·2019)[J]. 中华全科医师杂志, 2021, 20(1): 14-20.
[6]	杜剑, 高海燕. 替格瑞洛联合依诺肝素对非ST段抬高性急性冠状动脉综合征的疗效评价[J]. 实用临床医药杂志, 2019, 23(5): 59-61. doi: 10.7619/jcmp.201905014
[7]	LOPES, RENATO D, DE BARROS E SILVA, et al. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI[J]. the Journal of the American Medical Association, 2020, 323(8): 787-789. doi: 10.1001/jama.2020.0118
[8]	邓丽英, 许耘红. 同质医疗健康教育模式对冠心病病人PCI术后生活方式的影响[J]. 蚌埠医学院学报, 2019, 44(2): 123-125, 129. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201902037.htm
[9]	董霞, 王红, 刘成, 等. PCI术后1年患者主要不良心脏事件影响因素病例对照研究[J]. 护理学报, 2019, 26(20): 45-48. https://www.cnki.com.cn/Article/CJFDTOTAL-NFHL201920014.htm
[10]	宋长来, 付新, 孙江涛. 冠脉内注射尼可地尔对NSTEMI患者经皮冠状动脉介入治疗术中慢血流/无复流的影响及危险因素分析[J]. 河北医学, 2019, 25(8): 1249-1253. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX201908005.htm
[11]	谢楠, 李剑, 许璨. 老年急性冠脉综合征患者经皮冠状动脉介入治疗术后发生不良心脏事件的危险因素分析[J]. 中国循证心血管医学杂志, 2019, 11(9): 1121-1124. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201909029.htm
[12]	姚冰琪, 黄淑田, 葛婕丽, 等. 急性冠脉综合征患者经皮冠状动脉介入治疗后非罪犯血管病变进展危险因素及防治策略的研究进展[J]. 实用心脑肺血管病杂志, 2020, 28(6): 99-104. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL202006019.htm
[13]	ROY SWATHI, KINI ANNAPOORNA S, SWEENY JOSEPH M, et al. Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry[J]. Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions, 2018, 91(5): 859-866. http://www.ncbi.nlm.nih.gov/pubmed/28722295
[14]	张欢, 周小燕, 张露丹, 等. 老年冠心病患者PCI术后发生不良心脏事件的危险因素[J]. 昆明医科大学学报, 2019, 40(8): 57-62. https://www.cnki.com.cn/Article/CJFDTOTAL-KMYX201908013.htm
[15]	蒋丽珠, 柏岩, 尹姗姗, 等. 基线外周血中性粒细胞计数对急性冠脉综合征患者PCI预后的预测价值[J]. 郑州大学学报: 医学版, 2020, 55(3): 312-315. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202003005.htm
[16]	金春, 宋颖, 祖武, 等. 替格瑞洛与氯吡格雷对急性冠状动脉综合征患者经皮冠状动脉介入术后不良心脏事件的影响[J]. 疑难病杂志, 2017, 16(5): 433-436. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ201705001.htm
[17]	REDFORS, BJORN, CHEN, et al. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)[J]. The American Journal of Cardiology, 2019, 124(9): 1380-1388. http://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsRW5nTmV3UzIwMjEwMzAyEiA4ZDU4ZDc3MGYyZDQxNDc1MDMxMGE0NWZkYmY4ZGZlMBoINmVqNHRsc2k%3D

[1]	DONG Yindi, WU Ge, LI Guanhua. Efficacy and safety analysis of telitacicept in treatment of IgA nephropathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 62-66. DOI: 10.7619/jcmp.20230316
[2]	ZENG Lian. Efficacy and safety of methotrexate intramuscular injection combined with mifepristone oral administration for ectopic pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014
[3]	DONG Xinqiang, LI Peng, MENG Qingze, SUN Wengong. Efficacy and safety of microsurgery for young male patients with varicocele[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 81-83. DOI: 10.7619/jcmp.201910023
[4]	CHEN Shengpeng, JIANG Qiong. Efficacy and safety of progressive dose-adding of alprazolam midazolam in the treatment of chronic tinnitus[J]. Journal of Clinical Medicine in Practice, 2018, (11): 123-125. DOI: 10.7619/jcmp.201811036
[5]	LIU Zhigang, GONG Haitao. Clinical efficiency and safety of painless gastroscopy[J]. Journal of Clinical Medicine in Practice, 2018, (9): 101-103. DOI: 10.7619/jcmp.201809028
[6]	JIANG Yanli, WANG Xiujun, GAN Xiaoli. Effect of predictive nursing combined with enteral nutrition support on gastrointestinal function and quality of life in patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2016, (10): 51-54. DOI: 10.7619/jcmp.201610017
[7]	DENG Xiaolong, JI Wangqi. Efficacy and safety of hepatic arterial chemoembolization combined with radiofrequency ablation in treatment of patients with liver cancer[J]. Journal of Clinical Medicine in Practice, 2016, (3): 46-48,55. DOI: 10.7619/jcmp.201603014
[8]	FANG Chongwen. Efficacy and safety of endoscopic submucosal dissectionin the treatment of patients with digestive tract tumor[J]. Journal of Clinical Medicine in Practice, 2015, (21): 34-37. DOI: 10.7619/jcmp.201521009
[9]	WANG Jinwan, CAO Huqiang. Clinical efficacy and safety of 3-dimensional conformal radiotherapy combined with GT chemotherapy in the treatment of malignant bladder tumor[J]. Journal of Clinical Medicine in Practice, 2015, (19): 44-47. DOI: 10.7619/jcmp.201519013
[10]	ZHANG Ying. Efficacy and safety of montelukast in the treatment of cough variant asthma in infants[J]. Journal of Clinical Medicine in Practice, 2015, (11): 145-146. DOI: 10.7619/jcmp.201511051

Cited By

Cited by

Periodical cited type(5)

1.	万建平，周强. 经直肠超声造影检查联合血清前列腺特异性抗原检测对前列腺癌的诊断及预后预测价值. 癌症进展. 2025(02): 236-239 .
2.	李正平，李永芬，王生鹏. 前列腺尿道悬吊术对小体积良性前列腺增生患者下尿路功能、血清炎症-应激因子、并发症的影响. 微创泌尿外科杂志. 2025(01): 31-37 .
3.	王安勇，高余杰，黄学东，张衡，朱杰. 尿道前列腺切除术联合经尿道膀胱取石治疗老年前列腺增生伴膀胱结石的疗效及预后. 中国临床医生杂志. 2024(03): 290-294 .
4.	潘宗森，王慧. 经尿道前列腺钬激光剜除术在大体积良性前列腺增生中的应用效果. 浙江创伤外科. 2024(03): 538-541 .
5.	黄登辉，周广臣. 前列腺特异性抗原灰区患者前列腺穿刺活检结果的相关影响因素分析. 实用临床医药杂志. 2023(15): 77-81 . 本站查看

Other cited types(0)

Get Citation

PDF

XML

Article views (349) PDF downloads (33) Cited by(5)

Turn off MathJax

Article Contents

Abstract

References

Nursing management for percutaneous coronary intervention in patients with acute coronary syndrome